{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:55:22Z","timestamp":1791262522473,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110436","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:48:58Z","timestamp":1787669338000},"page":"110436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TAOK inhibitors for cancer therapy: current research progress and future directions"],"prefix":"10.1016","volume":"182","author":[{"given":"Fei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.110436_bb0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/cas.16078","article-title":"Progressive, multi-organ, and multi-layered nature of cancer cachexia","volume":"115","author":"Nakamura","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2026.110436_bb0010","doi-asserted-by":"crossref","first-page":"107763","DOI":"10.1016\/j.phrs.2025.107763","article-title":"The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy","volume":"216","author":"Zhang","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioorg.2026.110436_bb0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejmech.2019.05.027","article-title":"Natural products as multidrug resistance modulators in cancer","volume":"176","author":"Kumar","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc2823","article-title":"The regulatory crosstalk between kinases and proteases in cancer","volume":"10","author":"L\u00f3pez-Ot\u00edn","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110436_bb0025","first-page":"153","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bioorg.2026.110436_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejmech.2018.11.072","article-title":"Targeting the immunity protein kinases for immuno-oncology","volume":"163","author":"Yuan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0035","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2018.01.053","article-title":"Effects of rigidity on the selectivity of protein kinase inhibitors","volume":"146","author":"Assadieskandar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0040","doi-asserted-by":"crossref","first-page":"111581","DOI":"10.1016\/j.ejmech.2019.111581","article-title":"Small molecule modulators targeting protein kinase CK1 and CK2","volume":"181","author":"Qiao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110436_bb0045","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/ncb1258","article-title":"Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance","volume":"7","author":"MacKeigan","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110436_bb0050","doi-asserted-by":"crossref","first-page":"111629","DOI":"10.1016\/j.ejmech.2019.111629","article-title":"Discovery of phosphonamidate IDO1 inhibitors for the treatment of non-small cell lung cancer","volume":"182","author":"Du","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0055","doi-asserted-by":"crossref","first-page":"116952","DOI":"10.1016\/j.ejmech.2024.116952","article-title":"Discovery of CLKs inhibitors for the treatment of non-small cell lung cancer","volume":"280","author":"Hu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110436_bb0060","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/acs.jmedchem.9b01783","article-title":"Suppression of drug-resistant non-small-cell lung Cancer with inhibitors targeting minichromosomal maintenance protein","volume":"63","author":"Lin","year":"2020","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110436_bb0065","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1021\/acs.jmedchem.2c00408","article-title":"Discovery of potent OTUB1\/USP8 dual inhibitors targeting Proteostasis in non-small-cell lung Cancer","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110436_bb0070","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1535-7163.MCT-17-0077","article-title":"Targeting TAO kinases using a new inhibitor compound delays mitosis and induces mitotic cell death in centrosome amplified breast Cancer cells","volume":"16","author":"Koo","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.110436_bb0075","doi-asserted-by":"crossref","first-page":"112954","DOI":"10.1016\/j.ejmech.2020.112954","article-title":"Small-molecule inhibitors of breast cancer-related targets: potential therapeutic agents for breast cancer","volume":"210","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110436_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jacc.2016.03.319","article-title":"TCTAP C-112 a complex calcified lesion: a lesson learnt twice!","volume":"67","author":"Wong","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110436_bb0085","doi-asserted-by":"crossref","first-page":"15422","DOI":"10.1021\/acs.jmedchem.4c03233","article-title":"Development of the first small-molecule inhibitor targeting Oncostatin M for treatment of breast Cancer","volume":"68","author":"Wolf","year":"2025","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110436_bb0090","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/mc.23703","article-title":"Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo","volume":"63","author":"Song","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bioorg.2026.110436_bb0095","doi-asserted-by":"crossref","first-page":"117328","DOI":"10.1016\/j.ejmech.2025.117328","article-title":"Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the hippo pathway for the treatment of esophageal squamous cell carcinoma","volume":"287","author":"Wang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0100","doi-asserted-by":"crossref","first-page":"114909","DOI":"10.1016\/j.ejmech.2022.114909","article-title":"Novel thiazolidines of potential anti-proliferation properties against esophageal squamous cell carcinoma via ERK pathway","volume":"246","author":"Aziz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110436_bb0105","doi-asserted-by":"crossref","first-page":"14945","DOI":"10.1021\/acs.jmedchem.5c00987","article-title":"Discovery of 2-Pyrazolylpyrimidinone derivatives as new SPOP inhibitors for renal cell carcinoma therapy","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0110","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.cellbi.2007.08.006","article-title":"Human TAO kinase 1 induces apoptosis in SH-SY5Y cells","volume":"32","author":"Wu","year":"2013","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0115","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-024-02235-5","article-title":"The long noncoding RNA ELFN1-AS1 promotes gastric cancer growth and metastasis by interacting with TAOK1 to inhibit the hippo signaling pathway","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110436_bb0120","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s11596-025-00130-3","article-title":"LncRNA C9orf139 promotes acute myeloid Leukemia cell proliferation by sponging miR-24-3p to upregulate TAOK1","volume":"45","author":"Qin","year":"2025","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.bioorg.2026.110436_bb0125","doi-asserted-by":"crossref","first-page":"113523","DOI":"10.1016\/j.ejmech.2021.113523","article-title":"Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy","volume":"221","author":"Ayati","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejmech.2019.06.017","article-title":"Design, synthesis and activity of novel 2,6-disubstituted purine derivatives, potential small molecule inhibitors of signal transducer and activator of transcription 3","volume":"179","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110436_bb0135","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1158\/0008-5472.CAN-05-3489","article-title":"Frequent alterations in the expression of serine\/threonine kinases in human cancers","volume":"66","author":"Capra","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110436_bb0140","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0962-8924(01)01980-8","article-title":"The Ste20 group kinases as regulators of MAP kinase cascades","volume":"11","author":"Dan","year":"2001","journal-title":"Trends Cell Biol."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110436_bb0145","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1021\/acs.jmedchem.1c00631","article-title":"Strategies for targeting serine\/threonine protein phosphatases with small molecules in Cancer","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110436_bb0150","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1021\/acs.jmedchem.2c00604","article-title":"Discovery of potent and selective receptor-interacting serine\/threonine protein kinase 2 (RIPK2) inhibitors for the treatment of inflammatory bowel diseases (IBDs)","volume":"65","author":"Yuan","year":"2022","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110436_bb0155","doi-asserted-by":"crossref","first-page":"15120","DOI":"10.1021\/acs.jmedchem.5c01340","article-title":"Development of potent and selective RIPK1 degraders targeting its nonenzymatic function for Cancer treatment","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131079","article-title":"A Computational approach to discover potential quinazoline derivatives against CDK4\/6 kinase","volume":"1245","author":"Anant","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110436_bb0165","article-title":"Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output","volume":"17","author":"Hunter","year":"2019","journal-title":"PLoS Biol."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110436_bb0170","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.3390\/ijms21207463","article-title":"The diverse roles of TAO kinases in health and diseases","volume":"21","author":"Fang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110436_bb0175","doi-asserted-by":"crossref","first-page":"110917","DOI":"10.1016\/j.cellsig.2023.110917","article-title":"Comprehensive split TEV based protein-protein interaction screening reveals TAOK2 as a key modulator of hippo signalling to limit growth","volume":"113","author":"Ma","year":"2024","journal-title":"Cell. Signal."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110436_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050594","article-title":"JNK pathway activation is controlled by Tao\/TAOK3 to modulate ethanol sensitivity","volume":"7","author":"Kapfhamer","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110436_bb0185","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/sj.emboj.7601668","article-title":"TAO kinases mediate activation of p38 in response to DNA damage","volume":"26","author":"Raman","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2026.110436_bb0190","article-title":"TAOK1 promotes filament formation in HR repair through phosphorylating USP7","volume":"122","author":"Zhu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12964-020-00600-2","article-title":"Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-\u03baB signaling pathway","volume":"18","author":"Lai","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bioorg.2026.110436_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135596","article-title":"Identification of potential N-substituted 5-benzylidenethiazolidine-2,4-dione derivatives as \u03b1-amylase inhibitors: computational cum synthetic studies","volume":"1287","author":"Gupta","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110436_bb0205","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1093\/emboj\/cdg447","article-title":"MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK\/PAR-1","volume":"22","author":"Timm","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2026.110436_bb0210","doi-asserted-by":"crossref","first-page":"106558","DOI":"10.1016\/j.biocel.2024.106558","article-title":"A global phosphosite-correlated network map of thousand and one kinase 1 (TAOK1)","volume":"170","author":"Priyanka","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110436_bb0215","doi-asserted-by":"crossref","first-page":"18085","DOI":"10.1074\/jbc.M213064200","article-title":"The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability","volume":"278","author":"Mitsopoulos","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110436_bb0220","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41380-018-0025-5","article-title":"Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling","volume":"24","author":"Richter","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"19","key":"10.1016\/j.bioorg.2026.110436_bb0225","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1093\/emboj\/cdg447","article-title":"MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK\/PAR-1","volume":"22","author":"Timm","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bioorg.2026.110436_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106558","article-title":"A global phosphosite-correlated network map of thousand and one kinase 1 (TAOK1)","volume":"170","author":"Priyanka","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"47","key":"10.1016\/j.bioorg.2026.110436_bb0235","doi-asserted-by":"crossref","first-page":"33287","DOI":"10.1074\/jbc.274.47.33287","article-title":"Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor *","volume":"274","author":"Tassi","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110436_bb0240","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.devcel.2011.08.028","article-title":"Tao-1 phosphorylates hippo\/MST kinases to regulate the hippo-Salvador-warts tumor suppressor pathway","volume":"21","author":"Boggiano","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bioorg.2026.110436_bb0245","doi-asserted-by":"crossref","first-page":"28625","DOI":"10.1074\/jbc.273.44.28625","article-title":"Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades","volume":"273","author":"Hutchison","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.bioorg.2026.110436_bb0250","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1038\/sj.onc.1206605","article-title":"Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38","volume":"22","author":"Yustein","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2026.110436_bb0255","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1074\/jbc.M608336200","article-title":"Prostate-derived sterile 20-like kinase 1-\u03b1 induces apoptosis-JNK- and caspase-dependent nuclear localization is a requirement for membrane blebbing","volume":"282","author":"Zihni","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0260","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1074\/jbc.M513769200","article-title":"Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic morphology via C-Jun N-terminal kinase and rho Kinase-1","volume":"281","author":"Zihni","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bioorg.2026.110436_bb0265","doi-asserted-by":"crossref","first-page":"22278","DOI":"10.1074\/jbc.M301173200","article-title":"TAO (thousand-and-one amino acid) protein kinases mediate Signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110436_bb0270","doi-asserted-by":"crossref","first-page":"16070","DOI":"10.1074\/jbc.M100681200","article-title":"Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0275","doi-asserted-by":"crossref","first-page":"33287","DOI":"10.1074\/jbc.274.47.33287","article-title":"Human JIK, a novel member of the STE20 kinase family that inhibits JNK and is negatively regulated by epidermal growth factor","volume":"274","author":"Tassi","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0280","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.210773.112","article-title":"The hippo pathway: regulators and regulations","volume":"27","author":"Yu","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2026.110436_bb0285","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.devcel.2011.09.012","article-title":"The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-warts-hippo pathway","volume":"21","author":"Poon","year":"2011","journal-title":"Dev. Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110436_bb0290","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.molcel.2016.10.034","article-title":"Characterization of hippo pathway components by gene inactivation","volume":"64","author":"Plouffe","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2026.110436_bb0295","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1242\/jcs.068726","article-title":"Tao-1 is a negative regulator of microtubule plus-end growth","volume":"123","author":"Liu","year":"2010","journal-title":"J. Cell Sci."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110436_bb0300","doi-asserted-by":"crossref","first-page":"15418","DOI":"10.1074\/jbc.M112.448183","article-title":"Prostate-derived sterile 20-like kinases (PSKs\/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease","volume":"288","author":"Tavares","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.bioorg.2026.110436_bb0305","doi-asserted-by":"crossref","first-page":"30161","DOI":"10.1074\/jbc.M111.228320","article-title":"Prostate-derived sterile 20-like kinases (PSKs\/TAOKs) are activated in mitosis and contribute to mitotic cell rounding and spindle positioning","volume":"286","author":"Wojtala","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110436_bb0310","doi-asserted-by":"crossref","first-page":"18085","DOI":"10.1074\/jbc.M213064200","article-title":"The prostate-derived sterile 20-like kinase (PSK) regulates microtubule organization and stability","volume":"278","author":"Mitsopoulos","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0315","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1091\/mbc.e07-07-0730","article-title":"Spred1 and TESK1\u2014two new interaction Partners of the Kinase MARKK\/TAO1 that link the microtubule and actin cytoskeleton","volume":"19","author":"Johne","year":"2008","journal-title":"Mol. Biol. Cell"},{"issue":"44","key":"10.1016\/j.bioorg.2026.110436_bb0320","doi-asserted-by":"crossref","first-page":"28625","DOI":"10.1074\/jbc.273.44.28625","article-title":"Isolation of TAO1, a protein kinase that activates MEKs in stress-activated protein kinase cascades","volume":"273","author":"Hutchison","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110436_bb0325","doi-asserted-by":"crossref","first-page":"16070","DOI":"10.1074\/jbc.M100681200","article-title":"Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110436_bb0330","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1535-7163.MCT-17-0077","article-title":"Targeting TAO kinases using a new inhibitor compound delays mitosis and induces mitotic cell death in centrosome amplified breast Cancer cells","volume":"16","author":"Koo","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0335","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12964-020-00600-2","article-title":"Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-\u03baB signaling pathway","volume":"18","author":"Lai","year":"2020","journal-title":"Cell Commun. Signal"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110436_bb0340","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.devcel.2011.09.012","article-title":"The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-warts-hippo pathway","volume":"21","author":"Poon","year":"2011","journal-title":"Dev. Cell"},{"issue":"Pt 16","key":"10.1016\/j.bioorg.2026.110436_bb0345","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1242\/jcs.068726","article-title":"Tao-1 is a negative regulator of microtubule plus-end growth","volume":"123","author":"Liu","year":"2010","journal-title":"J. Cell Sci."},{"issue":"21","key":"10.1016\/j.bioorg.2026.110436_bb0350","doi-asserted-by":"crossref","first-page":"15418","DOI":"10.1074\/jbc.M112.448183","article-title":"Prostate-derived sterile 20-like kinases (PSKs\/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease","volume":"288","author":"Tavares","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0355","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3141","article-title":"Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex","volume":"15","author":"Anda","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110436_bb0360","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuron.2014.10.025","article-title":"MST3 kinase phosphorylates TAO1\/2 to enable myosin Va function in promoting spine synapse development","volume":"84","author":"Ultanir","year":"2014","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110436_bb0365","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41380-018-0025-5","article-title":"Altered TAOK2 activity causes autism-related neurodevelopmental and cognitive abnormalities through RhoA signaling","volume":"24","author":"Richter","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110436_bb0370","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuron.2016.12.006","article-title":"TAOK2 kinase mediates PSD95 stability and dendritic spine maturation through Septin7 phosphorylation","volume":"93","author":"Yadav","year":"2017","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0375","article-title":"Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma","volume":"15","author":"Guo","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00109-011-0831-6","article-title":"Comparative kinome analysis to identify putative colon tumor biomarkers","volume":"90","author":"Hennig","year":"2011","journal-title":"J. Mol. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110436_bb0385","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1021\/acs.jproteome.6b00613","article-title":"Activity-based protein profiling shows heterogeneous Signaling adaptations to BRAF inhibition","volume":"15","author":"Sharma","year":"2016","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0390","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1186\/1471-2164-10-476","article-title":"Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries","volume":"10","author":"Romanuik","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bioorg.2026.110436_bb0395","doi-asserted-by":"crossref","first-page":"15451","DOI":"10.18632\/oncotarget.24503","article-title":"Replication-incompetent gammaretroviral and lentiviral vectorbased insertional mutagenesis screens identify prostate cancer progression genes","volume":"9","author":"Bii","year":"2018","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110436_bb0400","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1158\/1535-7163.MCT-18-1011","article-title":"Target deconvolution of a multikinase inhibitor with antimetastatic properties identifies TAOK3 as a key contributor to a cancer stem cell\u2013like phenotype","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110436_bb0405","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1182\/blood-2009-07-234229","article-title":"Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique study","volume":"115","author":"Coyaud","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0410","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/ijms26041524","article-title":"Deferasirox targets TAOK1 to induce p53-mediated apoptosis in Esophageal squamous cell carcinoma","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0415","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41420-024-02235-5","article-title":"The long noncoding RNA ELFN1-AS1 promotes gastric cancer growth and metastasis by interacting with TAOK1 to inhibit the hippo signaling pathway","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041524","article-title":"Deferasirox targets TAOK1 to induce p53-mediated apoptosis in Esophageal squamous cell carcinoma","volume":"26","author":"Li","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0425","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00109-011-0831-6","article-title":"Comparative kinome analysis to identify putative colon tumor biomarkers","volume":"90","author":"Hennig","year":"2012","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230796","article-title":"Transcriptome analysis reveals gender-specific differences in overall metabolic response of male and female patients in lung adenocarcinoma","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110436_bb0435","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2422262122","article-title":"TAOK1 promotes filament formation in HR repair through phosphorylating USP7","volume":"122","author":"Zhu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0440","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.210773.112","article-title":"The hippo pathway: regulators and regulations","volume":"27","author":"Yu","year":"2013","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110436_bb0445","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1021\/acs.jproteome.6b00613","article-title":"Activity-based protein profiling shows heterogeneous Signaling adaptations to BRAF inhibition","volume":"15","author":"Sharma","year":"2016","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0450","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/slct.201702392","article-title":"Virtual screening, molecular docking, and DFT studies of some Thiazolidine-2,4-diones as potential PIM-1 kinase inhibitors","volume":"3","author":"Asati","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110436_bb0455","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.molstruc.2016.12.006","article-title":"3D-QSAR and virtual screening studies of thiazolidine-2,4-dione analogs: validation of experimental inhibitory potencies towards PIM-1 kinase","volume":"1133","author":"Asati","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110436_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137098","article-title":"Furan and benzofuran derivatives as privileged scaffolds as anticancer agents: SAR and docking studies (2010 to till date)","volume":"1299","author":"Patel","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110436_bb0465","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/1573409914666181003153249","article-title":"3D-QSAR and molecular docking studies on oxadiazole substituted benzimidazole derivatives: validation of experimental inhibitory potencies towards COX-2","volume":"15","author":"Asati","year":"2019","journal-title":"Curr. Comput. Aided Drug Des."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0470","doi-asserted-by":"crossref","DOI":"10.2174\/1574362418666221130164014","article-title":"In silico-based structural prediction, molecular docking and ADMET analysis of novel Imidazo-quinoline derivatives as pf purine nucleoside phosphorylase inhibitors","volume":"18","author":"Mallick","year":"2023","journal-title":"Curr. Signal Transduct. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0475","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/1574362416666210906155929","article-title":"Integrated computational analysis on some indolo-quinoline derivatives for the development of novel antiplasmodium agents: CoMFA, pharmacophore mapping, molecular docking and ADMET studies","volume":"17","author":"Mallick","year":"2022","journal-title":"Curr. Signal Transduct. Ther."},{"key":"10.1016\/j.bioorg.2026.110436_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128375","article-title":"Structural prediction of novel pyrazolo-pyrimidine derivatives against PIM-1 kinase: in-silico drug design studies","volume":"1217","author":"Asati","year":"2020","journal-title":"J. Mol. Struct."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110436_bb0485","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3141","article-title":"Autism spectrum disorder susceptibility gene TAOK2 affects basal dendrite formation in the neocortex","volume":"15","author":"Calderon de Anda","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bioorg.2026.110436_bb0490","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/acschemneuro.5c00906","article-title":"Discovery of VU6083859, a TAOK1 selective inhibitor, and VU6080195, a pan- TAOK activator","volume":"17","author":"Schultz","year":"2026","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110436_bb0495","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1021\/acschemneuro.5c00906","article-title":"Discovery of VU6083859, a TAOK1 selective inhibitor, and VU6080195, a pan-TAOK activator","volume":"17","author":"Schultz","year":"2026","journal-title":"ACS Chem. Neurosci."},{"issue":"16","key":"10.1016\/j.bioorg.2026.110436_bb0500","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.bmcl.2016.07.016","article-title":"Discovery of novel TAOK2 inhibitor scaffolds from high-throughput screening","volume":"26","author":"Piala","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110436_bb0505","doi-asserted-by":"crossref","first-page":"109286","DOI":"10.1016\/j.jmgm.2026.109286","article-title":"Structure-based discovery of novel TAOK3 inhibitor via virtual screening, molecular dynamics simulations, and MM\/GBSA analysis","volume":"144","author":"Alaseem","year":"2026","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2026.110436_bb0510","doi-asserted-by":"crossref","first-page":"117604","DOI":"10.1016\/j.taap.2025.117604","article-title":"Corylifol a ameliorates pancreatic cancer-associated cachexia by targeting TAOK3 in pancreatic cancer cells and targeting TAOK1 in skeletal muscle cells","volume":"505","author":"Yu","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0515","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/14756366.2020.1843452","article-title":"Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach","volume":"36","author":"Chao","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110436_bb0520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40203-022-00121-5","article-title":"Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia","volume":"10","author":"Rathore","year":"2022","journal-title":"In Silico Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110436_bb0525","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/14756366.2020.1843452","article-title":"Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach","volume":"36","author":"Chao","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110436_bb0530","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1158\/1535-7163.MCT-17-0077","article-title":"Targeting TAO kinases using a new inhibitor compound delays mitosis and induces mitotic cell death in centrosome amplified breast cancer cells","author":"Koo","year":"2017","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110436_bb0535","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2422262122","article-title":"TAOK1 promotes filament formation in HR repair through phosphorylating USP7","volume":"122","author":"Zhu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2026.110436_bb0540","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/sj.emboj.7601668","article-title":"TAO kinases mediate activation of p38 in response to DNA damage","volume":"26","author":"Raman","year":"2007","journal-title":"EMBO J."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826009727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:39:12Z","timestamp":1791261552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826009727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":108,"alternative-id":["S0045206826009727"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110436","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TAOK inhibitors for cancer therapy: current research progress and future directions","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110436"}}